Cormorant Asset Management, LP - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 119 filers reported holding KURA ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q4 2020$21,229,000
+38.6%
650,000
+30.0%
0.50%
-14.3%
Q3 2020$15,320,000
+34.3%
500,000
-28.6%
0.59%
+35.4%
Q2 2020$11,410,000
+43.3%
700,000
-12.5%
0.44%
+17.6%
Q1 2020$7,960,000
-42.1%
800,000
-20.0%
0.37%
-32.6%
Q4 2019$13,750,000
-26.4%
1,000,000
-18.8%
0.55%
-51.7%
Q3 2019$18,682,000
-32.2%
1,231,500
-12.0%
1.14%
-28.2%
Q2 2019$27,566,000
+18.7%
1,400,0000.0%1.58%
+0.8%
Q1 2019$23,226,000
+200.8%
1,400,000
+154.5%
1.57%
+150.4%
Q4 2018$7,722,000550,0000.63%
Other shareholders
KURA ONCOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders